Mechanistically, antitumor effects on bladder cancer cells were noted following treatment of berberine, exerted by inhibiting Janus kinase 1- STAT 3 signaling via miR-17-5p upregulation. The gene discussed is JAK1; the disease is urinary bladder carcinoma.